PDCD1 and neoplasm: Despite this, some investigations have indicated non-engineering approaches, such as IFN-γ treatment, that, while increasing PD-L1 expression by solid tumors, would also pave the way for bypassing PD-L1/PD-1 by enhancing ICAM-1 expression on tumor cells (264).